Cytokinetics's total assets for Q2 2025 were $1.23B, a decrease of -3.04% from the previous quarter. CYTK total liabilities were $1.59B for the fiscal quarter, a 4.17% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.